| 1. |
- Adriani, O., et al.
(författare)
-
Design of an Antimatter Large Acceptance Detector In Orbit (ALADInO)
- 2022
-
Ingår i: Instruments. - : MDPI AG. - 2410-390X. ; 6:2
-
Tidskriftsartikel (refereegranskat)abstract
- A new generation magnetic spectrometer in space will open the opportunity to inves-tigate the frontiers in direct high-energy cosmic ray measurements and to precisely measure the amount of the rare antimatter component in cosmic rays beyond the reach of current missions. We propose the concept for an Antimatter Large Acceptance Detector In Orbit (ALADInO), designed to take over the legacy of direct measurements of cosmic rays in space performed by PAMELA and AMS-02. ALADInO features technological solutions conceived to overcome the current limi-tations of magnetic spectrometers in space with a layout that provides an acceptance larger than 10 m2 sr. A superconducting magnet coupled to precision tracking and time-of-flight systems can provide the required matter–antimatter separation capabilities and rigidity measurement resolution with a Maximum Detectable Rigidity better than 20 TV. The inner 3D-imaging deep calorimeter, designed to maximize the isotropic acceptance of particles, allows for the measurement of cosmic rays up to PeV energies with accurate energy resolution to precisely measure features in the cosmic ray spectra. The operations of ALADInO in the Sun–Earth L2 Lagrangian point for at least 5 years would enable unique revolutionary observations with groundbreaking discovery poten-tials in the field of astroparticle physics by precision measurements of electrons, positrons, and antiprotons up to 10 TeV and of nuclear cosmic rays up to PeV energies, and by the possible unam-biguous detection and measurement of low-energy antideuteron and antihelium components in cosmic rays.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Battiston, R., et al.
(författare)
-
High precision particle astrophysics as a new window on the universe with an Antimatter Large Acceptance Detector In Orbit (ALADInO)
- 2021
-
Ingår i: Experimental astronomy. - : Springer Science and Business Media B.V.. - 0922-6435 .- 1572-9508. ; 51:3, s. 1299-1330
-
Tidskriftsartikel (refereegranskat)abstract
- Multimessenger astrophysics is based on the detection, with the highest possible accuracy, of the cosmic radiation. During the last 20 years, the advent space-borne magnetic spectrometers in space (AMS-01, Pamela, AMS-02), able to measure the charged cosmic radiation separating matter from antimatter, and to provide accurate measurement of the rarest components of Cosmic Rays (CRs) to the highest possible energies, have become possible, together with the ultra-precise measurement of ordinary CRs. These developments started the era of precision Cosmic Ray physics providing access to a rich program of high-energy astrophysics addressing fundamental questions like matter-antimatter asymmetry, indirect detection for Dark Matter and the detailed study of origin, acceleration and propagation of CRs and their interactions with the interstellar medium. In this paper we address the above-mentioned scientific questions, in the context of a second generation, large acceptance, superconducting magnetic spectrometer proposed as mission in the context of the European Space Agency’s Voyage2050 long-term plan: the Antimatter Large Acceptance Detector In Orbit (ALADInO) would extend by about two orders of magnitude in energy and flux sensitivity the separation between charged particles/anti-particles, making it uniquely suited for addressing and potentially solving some of the most puzzling issues of modern cosmology.
|
|
| 5. |
|
|
| 6. |
- Cottin, V, et al.
(författare)
-
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study
- 2018
-
Ingår i: ERJ open research. - : European Respiratory Society (ERS). - 2312-0541. ; 4:4
-
Tidskriftsartikel (refereegranskat)abstract
- Real-world studies include a broader patient population for a longer duration than randomised controlled trials (RCTs) and can provide relevant insights for clinical practice.PASSPORT was a multicentre, prospective, post-authorisation study of patients who were newly prescribed pirfenidone and followed for 2 years after initiating treatment. Physicians collected data on adverse drug reactions (ADRs), serious ADRs (SADRs) and ADRs of special interest (ADRSI) at baseline and then every 3 months. Post hoc stepwise logistic regression models were used to identify baseline characteristics associated with discontinuing treatment due to an ADR.Patients (n=1009, 99.7% with idiopathic pulmonary fibrosis) had a median pirfenidone exposure of 442.0 days. Overall, 741 (73.4%) patients experienced ADRs, most commonly nausea (20.6%) and fatigue (18.5%). ADRs led to treatment discontinuation in 290 (28.7%) patients after a median of 99.5 days. Overall, 55 (5.5%) patients experienced SADRs, with a fatal outcome in six patients. ADRSI were reported in 693 patients, most commonly gastrointestinal symptoms (38.3%) and photosensitivity reactions/skin rashes (29.0%). Older age and female sex were associated with early treatment discontinuation due to an ADR.Findings were consistent with the known safety profile of pirfenidone, based on RCT data and other post-marketing experience, with no new safety signals observed.
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
|
|
